AZD0901

(Synonyms: CMG901)

AZD0901 (CMG901) is an anti-CLDN18.2 antibody-drug conjugate. AZD0901 binds to CLDN18.2, undergoes internalization, disrupts microtubules, and causes direct cytotoxicity and bystander killing. AZD0901 induces ADCC and CDC through its retained IgG1 Fc. AZD0901 can be used in research on gastric or gastroesophageal junction adenocarcinoma and CLDN18.2-positive advanced solid tumors. AZD0901 consists of the antibody Sonesitatug (HY-P991026) and the toxin VcMMAE (HY-15575).

For research use only. We do not sell to patients.

  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00